UNAIDS
Collaborating with UNAIDS/WHO to Mobilize Support for the Implementation of Treatment 2.0 Strategies
Since November 2010, Pangaea has been assisting UNAIDS/ WHO in the development and implementation of Treatment 2.0 – the UNAIDS/WHO initiative launched in July 2010 focused on "catalysing the next phase of HIV treatment, care & support".
Pangaea is helping UNAIDS further refine and articulate the goals and objectives of Treatment 2.0, identifying and engaging all international and national partners, implementers, pharmaceutical and diagnostic companies and affected communities. The aim is to agree upon a common agenda for the next few years to enable significant improvements in treatment to be brought to people with HIV living in the developing world. Specific goals include:
- Define next generation of optimal therapies that provide long term benefit but can be easily sequenced;
- Develop affordable point of care diagnostics, either CD4 or Viral Load (VL) testing; and
- Make ARV drugs and testing more easily available through voluntary licenses and technology transfer.
The goal of this effort is to create a level playing field so that international and national policy makers – and people with HIV and their healthcare providers – can identify the optimal regimens for first and second line therapy – combined with the most effective use of diagnostic and monitoring technology and approaches. Pangaea's April 11, 2011 announcement provides more information.

